Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma
4CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy (Siège social : 29 avenue du Maréchal de Lattre de Tassigny, CO 60034, 54035 NANCY CEDEX
Hôpital Central : 29 Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy
Hôpitaux de Brabois / Enfants : Rue du Morvan, 54500 Vandœuvre-lès-Nancy
Maternité régionale :10 Avenue Dr Heydenreich, 54000 Nancy - France)
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01290429
Contributor : Laurent Jonchère <>
Submitted on : Friday, March 18, 2016 - 10:30:19 AM Last modification on : Wednesday, August 19, 2020 - 11:17:12 AM
Stephanie Guidez, Guillemette Fouquet, Helene Demarquette, Morgane Nudel, Eileen Boyle, et al.. Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma. Blood, American Society of Hematology, 2015, 126 (23), pp.5379. ⟨hal-01290429⟩